{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T02:52:33Z","timestamp":1769914353763,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jns.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T23:32:10Z","timestamp":1529019130000},"page":"104-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Epilepsy treatment patterns among patients with tuberous sclerosis complex"],"prefix":"10.1016","volume":"391","author":[{"given":"Jinlin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qayyim","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Peeples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Meiselbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kohrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Korf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Sparagana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jns.2018.06.011_bb0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jns.2018.06.011_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1357-4310(98)01245-3","article-title":"The genetic basis of tuberous sclerosis","volume":"4","author":"Young","year":"1998","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.jns.2018.06.011_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jns.2018.06.011_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease awareness (TOSCA) - baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.jns.2018.06.011_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pediatrneurol.2011.01.001","article-title":"Cortical tubers, cognition, and epilepsy in tuberous sclerosis","volume":"44","author":"Kassiri","year":"2011","journal-title":"Pediatr. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2018.06.011_bb0030","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/adc.2011.211995","article-title":"The tuberous sclerosis 2000 study: presentation, initial assessments and implications for diagnosis and management","volume":"96","author":"Yates","year":"2011","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.jns.2018.06.011_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.jns.2018.06.011_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.yebeh.2011.08.037","article-title":"Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis","volume":"22","author":"Cusmai","year":"2011","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.jns.2018.06.011_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jmg.28.6.395","article-title":"On the incidence of fits and mental retardation in tuberous sclerosis","volume":"28","author":"Webb","year":"1991","journal-title":"J. Med. Genet."},{"issue":"7","key":"10.1016\/j.jns.2018.06.011_bb0050","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jns.2018.06.011_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2018.06.011_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.jns.2018.06.011_bb0065","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jns.2018.06.011_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5698\/1535-7597-14.3.143","article-title":"Treating epilepsy in tuberous sclerosis with everolimus: getting closer","volume":"14","author":"Miller","year":"2014","journal-title":"Epilepsy Curr."},{"issue":"10056","key":"10.1016\/j.jns.2018.06.011_bb0075","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jns.2018.06.011_bb0080","unstructured":"European Medical Agency. Affinitor: EPAR - Product Information. Accessed on: November 22, 2017. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001038\/WC500022814.pdf."},{"issue":"8","key":"10.1016\/j.jns.2018.06.011_bb0085","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/epi.13050","article-title":"Epilepsy in children with tuberous sclerosis complex: chance of remission and response to antiepileptic drugs","volume":"56","author":"Overwater","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2018.06.011_bb0090","unstructured":"TSC Natural History Database. Accessed on: March 3rd, 2015. Available from: http:\/\/www.tsalliance.org\/researchers\/natural-history-database\/."},{"issue":"4","key":"10.1016\/j.jns.2018.06.011_bb0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2018.06.011_bb0100","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/epi.13467","article-title":"Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex","volume":"57","author":"Jeong","year":"2016","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.jns.2018.06.011_bb0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1469-8749.1996.tb12086.x","article-title":"Morbidity associated with tuberous sclerosis: a population study","volume":"38","author":"Webb","year":"1996","journal-title":"Dev. Med. Child Neurol."},{"issue":"20","key":"10.1016\/j.jns.2018.06.011_bb0110","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2018.06.011_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1017\/S109285290000849X","article-title":"Understanding the delay before epilepsy surgery: who develops intractable focal epilepsy and when?","volume":"9","author":"Berg","year":"2004","journal-title":"CNS Spectrums"},{"issue":"13","key":"10.1016\/j.jns.2018.06.011_bb0120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1503\/cmaj.121291","article-title":"Surgical management of epilepsy","volume":"186","author":"Jette","year":"2014","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.jns.2018.06.011_bb0125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/ene.13005","article-title":"Long-term prognosis of epilepsy, prognostic patterns and drug resistance: a population-based study","volume":"23","author":"Giussani","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2018.06.011_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13696998.2016.1199432","article-title":"The economic burden of tuberous sclerosis complex in the UK: a retrospective cohort study in the clinical practice research datalink","volume":"19","author":"Kingswood","year":"2016","journal-title":"J. Med. Econ."},{"issue":"2","key":"10.1016\/j.jns.2018.06.011_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet. Med."},{"issue":"5327","key":"10.1016\/j.jns.2018.06.011_bb0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jns.2018.06.011_bb0145","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis C","year":"1993","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.jns.2018.06.011_bb0150","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jns.2018.06.011_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ng0294-193","article-title":"Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients","volume":"6","author":"Green","year":"1994","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.jns.2018.06.011_bb0160","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1086\/302648","article-title":"Complete inactivation of the TSC2 gene leads to formation of hamartomas","volume":"65","author":"Au","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jns.2018.06.011_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1470-2045(07)70411-4","article-title":"Possible mechanisms of disease development in tuberous sclerosis","volume":"9","author":"Jozwiak","year":"2008","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.jns.2018.06.011_bb0170","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/157015912804499537","article-title":"mTOR inhibitors in tuberous sclerosis complex","volume":"10","author":"Curatolo","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jns.2018.06.011_bb0175","unstructured":"Administration USFaD. Highlights of Prescribing Information: AFINITOR (Everolimus). Accessed on: May 26, 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022334s016lbl.pdf."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:44:39Z","timestamp":1758383079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18302612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"alternative-id":["S0022510X18302612"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.06.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy treatment patterns among patients with tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}